Journey Medical Corp
DERM· Nasdaq
Released Mar 25, 2026, after the close
10-K filed Mar 26, 2026, 85 days after period end · 0001104659-26-034629
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $16.69M | $13.62M | $15.26M | $15.92M |
| Net Income | -$1.25M |
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR
| $1.52M |
| -$2.14M |
| -$10.64M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.